You're reading everything related to:
Key Insights From The Pharmaceutical Cannabis Report
Key Insights From CBD: The Consumer Report
CBD: The Consumer Report is the latest release in the suite of Prohibition Partners’ market-leading consumer research reports, providing proprietary data on over 15,000 adults from seven key global markets,...
Synthetic cannabinoid firm’s stock tanks 77% after failed clinical trials
Corbus Pharmaceuticals, one of the leaders in the pharmaceutical cannabinoid industry takes a hit as their lead drug fails in advanced clinical trials.
Australian medical cannabis approvals rising despite COVID-19 disruptions
After a quarter of stalled growth, approvals for cannabis-based medicines via the SAS-B route is now accelerating once more.
Europe is recording one million cannabis offences a year
Drug offences involving cannabis are following a stable, albeit slightly rising trend in Europe, which registers over one million cannabis offences each year, despite the fact that over 25 million...
European medical cannabis trade: Southern Europe becoming largest supplier
The rising demand for medical cannabis in Europe, driven primarily by maturing markets such as Germany, Italy and the Netherlands, has opened the door to new sources for medical cannabis...